Clinical Trial Update: "Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients" [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial investigating strategies to prevent paclitaxel-induced peripheral neuropathy in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Peripheral Neuropathy

Snippet

Sponsor: Ain Shams University | Conditions: Breast Cancer Female, Peripheral Neuropathy | Phase 2, Phase 3 | Status: COMPLETED